GlassScriptPhysician profile
Apostolos John Giannas
NPI 1790906378
$2,325.03
in general payments reported to CMS, 2019-2025
23 companies · $241 in 2025
The $241 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $355 · 2021: $328 · 2022: $636 · 2023: $365 · 2024: $225 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $831.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $830.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $446.83 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $325.50 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $260.61 | 2020-2023 | Cequa |
| Allergan, INC. | $233.49 | 2020-2022 | |
| Tarsus Pharmaceuticals, INC. | $131.15 | 2024-2025 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $126.29 | 2020-2022 | |
| New World Medical,INC. | $123.61 | 2025 | Clearpath, Kahook Dual Blade, Via360 |
| Novartis Pharmaceuticals Corporation | $107.00 | 2020-2022 | |
| Abbvie INC. | $105.89 | 2022-2024 | |
| Coopervision INC. | $85.00 | 2022 | |
| Shire North American Group INC | $65.96 | 2019 | |
| Oyster Point Pharma, INC. | $46.09 | 2022-2023 | Tyrvaya |
| Tearlab Corp | $45.97 | 2019 | |
| Alcon Vision LLC | $38.42 | 2022 | |
| Aerie Pharmaceuticals, INC. | $29.41 | 2020-2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $24.28 | 2021 | |
| Thea Pharma INC. | $21.94 | 2023 | |
| Glaukos Corporation | $21.68 | 2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Regeneron Healthcare Solutions, INC. | $21.07 | 2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Omeros Corporation | $15.91 | 2020 | |
| Eyevance Pharmaceuticals LLC | $12.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Apostolos Giannas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.